Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. - Wikidata - awgldk - TriplyDB

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

http://www.wikidata.org/entity/Q34544992

about

Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions Outcomes of transjugular intrahepatic portosystemic shunts for ascites Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications Transjugular intrahepatic portosystemic shunt Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices Protective value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO).Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.Cirrhosis and its complications: evidence based treatment.Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis Review article: hepatic hydrothorax.Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis.Liver failure after an uncovered TIPS procedure associated with hepatic infarction Current management of the complications of portal hypertension: variceal bleeding and ascites.Acute esophageal variceal bleeding: Current strategies and new perspectives Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis.Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS.Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistance Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.Effect of technical parameters on transjugular intrahepatic portosystemic shunts utilizing stent grafts.Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.Refractory ascites.Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.Parallel shunt for the treatment of transjugular intrahepatic portosystemic shunt dysfunction.Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial.Transjugular intrahepatic portosystemic shunt combined with esophagogastric variceal embolization in the treatment of a large gastrorenal shunt.Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.Evaluation and management of patients with refractory ascites.Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt.Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.Ascites: pathogenesis and therapeutic principles.Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.

P2860

Q26744689-34B3187C-EDAB-4449-88A0-85EBB9BEC7D3 Q26850530-BBBCC444-C215-4E83-BCBB-B68618EFFE38 Q26860685-986F4A05-6304-4291-B5EC-21DA8D972E7B Q26991832-00AA1F3B-F86C-423D-871D-2C3FDA5DF3D3 Q27025642-C7E8412F-B871-4859-A44C-016AD32F9274 Q30240056-E0AB3A1A-FEE5-4252-B632-49148865BABB Q30425319-36BF0659-3736-4065-ADDE-D5687C240130 Q30456874-56C50EDB-7AB7-4B4E-9B5E-8D6EB1DF338B Q33401230-366CA09A-FC2C-4858-8B1D-519423ED64AE Q33594931-2A73FF13-0C38-4708-A480-B444EBF6146F Q33596518-0D5739B0-D539-46F9-93D4-4E127BB7A723 Q33607938-1439CDAB-DA0A-4516-90D5-C2B654FA10D5 Q33621279-E97E2BFE-53E0-4BE9-93E6-69A693D856A5 Q33980197-BC2B9A45-6EA5-4FF3-A50E-67E1371DB465 Q34093871-F5247DC8-4291-42E2-8309-BF287EAEDDC0 Q34390250-95429FE0-F51E-4732-B4BF-7610D190016A Q34523099-32CDF12C-C45F-4853-870A-E7BECE2B0BF4 Q34625821-B3BD724B-8D05-4051-B3DF-A47ACF185D96 Q35015492-282D8FF9-84E0-4AD1-8137-F3E6CD49E861 Q35045432-9015FE04-CBF4-4150-8623-20A5D2435377 Q35064544-126E3B0C-4E53-4B48-98B2-F12401F8E269 Q35435269-90FFD361-8A7A-46D2-9281-064B54776339 Q35843074-92A64951-8D6D-455A-982D-68DC8B3E4922 Q36075767-4731FB61-A643-4319-A691-F89609CE88B1 Q36141433-02D074F1-869E-4279-AC27-DB43F7F9962A Q36305703-F48AFCD5-A1D6-418C-898B-37DCEEBA9ECF Q36310424-C2CB67E1-66DE-4250-991C-030E5EDB3B17 Q36510687-899FCBF8-2E16-4E58-BB24-55B87DB68024 Q36529243-0A096401-57A2-45D8-9E70-CDAE2DA07A3B Q36847761-00C7E721-1456-4C71-AC49-42111F733708 Q36971714-9D31D4D0-99BF-4417-824B-653AB8375352 Q37011204-25F8EF88-236B-437E-91E6-82240E4E6A19 Q37095760-3ED18B5F-5D5F-46C2-85ED-BC7308B2FDF4 Q37102443-9009A32E-47A1-4C10-B8A8-A63AFDE998B9 Q37122130-6EA4E413-B10B-41B1-A1D9-D5DC506E78F4 Q37344458-D3CD98E4-1FEA-442C-A68F-8D3334F51B29 Q37358670-30363291-117B-4D4A-ABC5-806CBC43B7BE Q37489472-8DD4E86C-B960-41E5-BB2C-56BFE06BC610 Q37500169-FA06F16E-D36B-4E01-8241-01CF09BAAD89 Q37578597-AC5235F8-35E0-46EF-A86B-E466417D3D00

P2860

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

http://www.wikidata.org/entity/Q34544992

description

2004 nî lūn-bûn

@nan

2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Improved clinical outcome usin ...... results of a randomized study.

@ast

Improved clinical outcome usin ...... results of a randomized study.

@en

Improved clinical outcome usin ...... results of a randomized study.

@nl

type

label

Improved clinical outcome usin ...... results of a randomized study.

@ast

Improved clinical outcome usin ...... results of a randomized study.

@en

Improved clinical outcome usin ...... results of a randomized study.

@nl

prefLabel

Improved clinical outcome usin ...... results of a randomized study.

@ast

Improved clinical outcome usin ...... results of a randomized study.

@en

Improved clinical outcome usin ...... results of a randomized study.

@nl

P1433

Q34544992-47714143-BAEC-43AE-9858-55B88A309A53

P1476

Q34544992-71A53D16-743B-409F-A9F6-1DBE8A76ED54

P2093

Q34544992-0A48698C-F4D8-4513-B34D-57E1709C745D

Q34544992-573D4078-A596-4B92-B301-B3B6857408F1

Q34544992-60C976DD-2292-42E1-A1C3-1CD554F03F3E

Q34544992-6208BBB1-A04D-499B-BA9A-A8FAB6AE9196

Q34544992-68423413-9294-4DCC-BF1F-FE9E9EFC8884

Q34544992-8968C885-0A22-4080-8304-0402E7B9A55E

Q34544992-8AF18EFE-034F-40D1-8904-52AB184FA4BC

Q34544992-970C7041-70FF-4141-9707-B53241F41268

Q34544992-B6815F7B-337D-4527-B8AB-754F3CC4A40C

Q34544992-BA8A301F-335E-4A6D-AD58-5DDD898BB2BB

P304

Q34544992-19201586-F69B-427A-AEBA-A475EF9B1C45

P31

Q34544992-71B58AEC-CC04-413A-A9C9-61AB9CB46EBA

P356

Q34544992-0608BB4E-0858-4495-80C8-1DE0957C71ED

P407

Q34544992-4DBD8A1E-531F-4B54-B87C-5C9F3342B3C3

P433

Q34544992-873C329F-069D-45B6-80A9-B6C182719CB1

P478

Q34544992-37AD0A9F-BD20-4779-8F16-3F5E1233FD0D

P50

Q34544992-B212B8D5-1BEA-4F80-A8F6-1F552B053079

Q34544992-D3B1F77B-ADE6-409A-B85B-800456F3D149

P577

Q34544992-744AF65F-F8F3-4269-A8E1-96FEF7FC3FCD

P698

Q34544992-92CB41B1-0B17-4968-BB5D-AC053F48797A

P356

J.GASTRO.2003.11.016

P1433

Gastroenterology

P1476

Improved clinical outcome usin ...... results of a randomized study

@en

P2093

Carlos Cortez

http://www.w3.org/2001/XMLSchema#string

Christophe Bureau

http://www.w3.org/2001/XMLSchema#string

Gilles Pomier-Layrargues

http://www.w3.org/2001/XMLSchema#string

Hervé Rousseau

http://www.w3.org/2001/XMLSchema#string

Jaume Bosch

http://www.w3.org/2001/XMLSchema#string

Jean Marie Péron

http://www.w3.org/2001/XMLSchema#string

Jean Pierre Vinel

http://www.w3.org/2001/XMLSchema#string

Juan G Abraldes

http://www.w3.org/2001/XMLSchema#string

Louis Bouchard

http://www.w3.org/2001/XMLSchema#string

Philippe Otal

http://www.w3.org/2001/XMLSchema#string

P304

469-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2003.11.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

126

http://www.w3.org/2001/XMLSchema#string

P50

Juan Carlos García-Pagan

José Ignacio Bilbao

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14762784

http://www.w3.org/2001/XMLSchema#string